YOLFTbeta
Sera Prognostics Inc

Sera Prognostics Inc

SERA · NASDAQ · Healthcare / Medical Devices

2.01USD+0.03 (+1.52%)

Price History

Full chart

Market Stats

Previous Close1.98
Open1.96
Day Range1.95 – 2.04
52-Week Range1.56 – 3.95
Volume28.13K
Market Cap80.48M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.66
Dividend Yield0.00%
Beta0.98
50-Day Avg2.06
200-Day Avg2.30

About

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Zhenya Lindgardt M.B.A.
  • Employees71
  • Headquarters2749 East Parleys Way, Salt Lake City, UT, United States, 84109, USA
  • Websitehttps://www.sera.com

Leadership

  • Ms. Zhenya Lindgardt M.B.A.President, CEO & Director · b. 1974
  • Dr. John J. Boniface Ph.D.Chief Scientific Officer · b. 1962
  • Dr. Gregory C. Critchfield M.D., M.S.Executive Director · b. 1953
  • Dr. Paul Kearney Ph.D.Chief Data Officer · b. 1968
  • Mr. Scott GleasonCFO & Treasurer · b. 1979
  • Mr. Robert G. HarrisonChief Information Officer · b. 1966
  • Ms. Jennifer ZibudaHead of Investor Relations
  • Mr. Benjamin G. Jackson J.D.General Counsel & Corporate Secretary · b. 1979
  • Mr. Lee AndersonChief Commercial Officer
  • Mr. Chuck HydeHead of Market Access

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue36.00K25.00K82.00K268.00K306.00K77.00K81.00K
Growth (%)--30.56%+228.00%+226.83%+14.18%-74.84%+5.19%
Cost of Revenue18.00K11.00K37.00K193.00K210.00K82.00K164.00K
Gross Profit18.00K14.00K45.00K75.00K96.00K-5.00K-83.00K
Gross Margin50.00%56.00%54.88%27.99%31.37%-6.49%-102.47%
Operating Expense16.59M17.98M35.44M45.73M39.92M36.63M36.42M
Operating Income-16.58M-17.97M-35.40M-45.65M-39.82M-36.63M-36.50M
Operating Margin-46044.44%-71884.00%-43164.63%-17034.33%-13013.40%-47577.92%-45066.67%
EBITDA-13.60M-17.11M-33.60M-43.37M-35.29M-32.04M-30.98M
EBITDA Margin-37786.11%-68456.00%-40980.49%-16182.46%-11531.70%-41606.49%-38245.68%
Net Income-16.52M-19.85M-35.01M-44.19M-36.24M-32.90M-31.93M
Net Income Margin-45891.67%-79392.00%-42693.90%-16487.31%-11843.79%-42724.68%-39417.28%
R&D9.35M7.78M11.02M14.24M15.22M14.73M13.17M
R&D as % of Total Revenue25980.56%31128.00%13437.80%5314.93%4975.49%19129.87%16260.49%
Interest Expense1.97M1.84M746.00K61.00K55.00K28.00K9.00K
Interest Expense % of Total Revenue5477.78%7356.00%909.76%22.76%17.97%36.36%11.11%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets23.26M14.80M147.03M116.33M95.44M72.58M101.93M
Total Liabilities12.30M11.86M8.46M17.39M25.28M24.77M26.52M
Total Equity10.96M2.94M138.56M98.94M70.16M47.80M75.41M
Cash21.39M13.53M58.93M29.88M3.88M4.04M3.94M
Total Debt9.31M8.57M128.00K2.83M1.86M840.00K2.34M
Net Debt-12.07M-4.96M-58.80M-27.05M-2.02M-3.20M-1.60M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-19.32M-16.87M-31.64M-34.61M-27.19M-14.19M-25.62M
Investing Cash Flow-6.00K-149.00K-82.56M5.55M438.00K11.74M-28.50M
Financing Cash Flow33.05M9.16M159.59M5.00K752.00K2.61M54.03M
Capital Expenditure109.00K149.00K1.30M791.00K128.00K1.10M726.00K
Free Cash Flow-19.43M-17.02M-32.94M-35.40M-27.32M-15.29M-26.35M
FCF to OCF100.56%100.88%104.12%102.29%100.47%107.76%102.83%

Earnings

Report DateMar 31, 2020Mar 31, 2021Jun 2, 2021Aug 30, 2021Nov 9, 2021Mar 29, 2022May 10, 2022Aug 10, 2022Nov 9, 2022Mar 22, 2023May 10, 2023Aug 9, 2023Nov 8, 2023Mar 20, 2024May 8, 2024Aug 7, 2024Nov 6, 2024Mar 19, 2025May 7, 2025Aug 6, 2025Nov 13, 2025Mar 25, 2026May 6, 2026Aug 12, 2026Nov 12, 2026
EPS Estimate0.000.00-0.17-1.26-0.25-0.29-0.37-0.41-0.62-0.37-0.38-0.36-0.35-0.26-0.27-0.26-0.22-0.23-0.21-0.24-0.21-0.19-0.17-0.14-0.14
EPS Actual-1.48-1.71-0.17-3.17-0.39-0.41-0.40-0.37-0.35-0.31-0.34-0.34-0.23-0.25-0.25-0.25-0.24-0.25-0.20-0.16-0.16-0.16-0.17-0.18-
Surprise--0.00%-151.59%-56.00%-41.38%-8.11%9.76%43.55%16.22%10.53%5.56%34.29%3.85%7.41%3.85%-9.09%-8.70%4.76%33.33%23.81%13.70%0.00%-28.57%-
Timing---After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap80.48M
Enterprise Value38.22M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1149.67
Price / Book1.38
EPS-0.66
Book Value1.51
Revenue (TTM)70.00K
Gross Profit (TTM)-105.00K
EBITDA-36.54M
Profit Margin0.00%
Operating Margin-33346.67%
Return on Equity-45.03%
Return on Assets-23.48%
Shares Outstanding38.48M
Shares Float27.71M
Beta0.98
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 5.50
  • Strong Buy
    2

Ownership Breakdown

Institutions
50.21%
Insiders
12.13%
Retail / Other
37.66%

Top Institutional Holders

  • Baker Bros Advisors LP
    5.50M13.94%
  • Whetstone Capital Advisors, LLC
    3.31M8.38%
  • Aberdeen Group PLC
    2.75M6.98%
  • Vivo Capital, LLC
    1.65M4.18%
  • Vanguard Capital Management, LLC
    1.20M3.05%
  • CapTrust Financial Advisors
    536.76K1.36%
  • Geode Capital Management, LLC
    363.62K0.92%
  • Awm Investment Company Inc
    207.38K0.53%
  • BlackRock Inc
    196.10K0.50%
  • Vanguard Fiduciary Trust Co
    169.66K0.43%
  • State Street Corp
    124.79K0.32%
  • Morgan Stanley - Brokerage Accounts
    105.02K0.27%
  • Northern Trust Corp
    96.53K0.24%
  • Millennium Management LLC
    73.99K0.19%
  • Perigon Wealth Management, LLC
    72.69K0.18%

Top Fund Holders

  • abrdn Healthcare Opportunities
    1.43M3.63%
  • abrdn Healthcare Investors
    1.43M3.63%
  • Vanguard MStar Total Stk Mkt Idx Invest
    887.02K2.25%
  • Fidelity Extended Market Index
    162.23K0.41%
  • iShares Micro-Cap ETF
    101.69K0.26%